Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)
PHASE3CompletedINTERVENTIONAL
Enrollment
631
Participants
Timeline
Start Date
June 30, 2002
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Conditions
Chronic Hepatitis CCirrhosis
Interventions
BIOLOGICAL
peginterferon alfa-2b (SCH 54031)
0.5 µg/kg subcutaneously once weekly for 60 months
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00048724 - Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569) | Biotech Hunter | Biotech Hunter